New York State Teachers Retirement System boosted its position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 18.1% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 266,235 shares of the company's stock after purchasing an additional 40,793 shares during the period. New York State Teachers Retirement System owned about 0.12% of Bath & Body Works worth $8,498,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in BBWI. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in shares of Bath & Body Works by 28.1% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 258,617 shares of the company's stock worth $12,936,000 after buying an additional 56,764 shares during the last quarter. Russell Investments Group Ltd. grew its position in shares of Bath & Body Works by 46.9% during the 1st quarter. Russell Investments Group Ltd. now owns 131,605 shares of the company's stock valued at $6,572,000 after acquiring an additional 41,995 shares during the period. Vanguard Group Inc. increased its stake in shares of Bath & Body Works by 4.2% during the 1st quarter. Vanguard Group Inc. now owns 27,398,192 shares of the company's stock worth $1,370,458,000 after purchasing an additional 1,102,124 shares during the last quarter. SG Americas Securities LLC raised its holdings in shares of Bath & Body Works by 968.1% in the 1st quarter. SG Americas Securities LLC now owns 190,758 shares of the company's stock worth $9,542,000 after purchasing an additional 172,898 shares during the period. Finally, UniSuper Management Pty Ltd lifted its stake in Bath & Body Works by 576.9% in the first quarter. UniSuper Management Pty Ltd now owns 22,799 shares of the company's stock valued at $1,140,000 after purchasing an additional 19,431 shares during the last quarter. Hedge funds and other institutional investors own 95.14% of the company's stock.
Analyst Upgrades and Downgrades
Several analysts have issued reports on BBWI shares. Barclays lowered their target price on Bath & Body Works from $32.00 to $31.00 and set an "equal weight" rating on the stock in a research note on Thursday, August 29th. Citigroup dropped their price objective on shares of Bath & Body Works from $48.00 to $35.00 and set a "neutral" rating on the stock in a report on Tuesday, August 20th. Wells Fargo & Company reduced their target price on shares of Bath & Body Works from $48.00 to $40.00 and set an "equal weight" rating for the company in a research note on Wednesday, July 24th. Bank of America dropped their price target on shares of Bath & Body Works from $54.00 to $45.00 and set a "buy" rating on the stock in a research note on Thursday, August 29th. Finally, Robert W. Baird lowered their target price on shares of Bath & Body Works from $54.00 to $45.00 and set an "outperform" rating on the stock in a report on Thursday, August 29th. Seven analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $43.13.
Get Our Latest Stock Analysis on Bath & Body Works
Bath & Body Works Trading Up 8.2 %
NYSE BBWI traded up $2.36 during trading on Monday, hitting $31.28. The company had a trading volume of 7,808,956 shares, compared to its average volume of 3,729,028. The company's fifty day moving average is $30.16 and its 200-day moving average is $37.38. The company has a market cap of $6.85 billion, a price-to-earnings ratio of 7.42, a price-to-earnings-growth ratio of 0.90 and a beta of 1.79. Bath & Body Works, Inc. has a one year low of $26.20 and a one year high of $52.99.
Bath & Body Works (NYSE:BBWI - Get Free Report) last released its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, topping analysts' consensus estimates of $0.35 by $0.02. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. The firm had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.54 billion. As a group, equities analysts anticipate that Bath & Body Works, Inc. will post 3.18 EPS for the current year.
Bath & Body Works Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, September 6th. Shareholders of record on Friday, August 23rd were paid a dividend of $0.20 per share. The ex-dividend date was Friday, August 23rd. This represents a $0.80 dividend on an annualized basis and a yield of 2.56%. Bath & Body Works's dividend payout ratio is currently 19.37%.
Insiders Place Their Bets
In other news, CEO Gina Boswell purchased 6,000 shares of Bath & Body Works stock in a transaction that occurred on Wednesday, October 9th. The stock was bought at an average price of $29.64 per share, with a total value of $177,840.00. Following the completion of the transaction, the chief executive officer now directly owns 242,987 shares of the company's stock, valued at approximately $7,202,134.68. The trade was a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.27% of the company's stock.
Bath & Body Works Company Profile
(
Free Report)
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
Read More
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.